CNMD Stock: Price, Earnings History and SEC Filings
CONMED Corporation (CNMD) last traded at $44.29, down 3.13% on the latest session and down 4.2% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.04 against an analyst estimate of $1.00, a beat of 4.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CNMD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.04 | $1.00 | +4.00% |
| Jun 2026 | Jul 29, 2026 | $1.38 | $1.10 | +25.45% |
| Mar 2026 | Apr 29, 2026 | $0.89 | $0.82 | +8.54% |
| Dec 2025 | Jan 28, 2026 | $1.43 | $1.32 | +8.33% |
CNMD beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How CNMD reacts to earnings
Across its last 8 earnings releases, CNMD moved 5.3% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | After close | -0.09% |
| 2026-07-29 | After close | +8.72% |
| 2026-04-29 | After close | +1.95% |
| 2026-01-28 | After close | -3.57% |
| 2025-11-05 | After close | -0.52% |
| 2025-07-30 | After close | +2.01% |
| 2025-04-30 | After close | +16.45% |
| 2025-02-05 | After close | -8.97% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
CNMD financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $1.4B | $47M | $151M | 3.4% | $1.51 |
| 2024 | $1.3B | $132M | $154M | 10.1% | $4.25 |
| 2023 | $1.2B | $64M | $106M | 5.2% | $2.04 |
| 2022 | $1.0B | -$81M | $12M | -7.7% | $-2.68 |
| 2021 | $1.0B | $63M | $97M | 6.2% | $1.94 |
| 2020 | $862M | $10M | $52M | 1.1% | $0.32 |
| 2019 | $955M | $29M | $75M | 3.0% | $0.97 |
| 2018 | $860M | $41M | $58M | 4.8% | $1.41 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CNMD
- 10-Q · Oct 28, 2026
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 10-Q · Jul 29, 2026
- 8-K · Jul 29, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 17, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jun 4, 2026Material agreement, Financial statements and exhibits
- 8-K · Jun 1, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 8-K · May 20, 2026Officer or director change, Bylaw change, Shareholder vote
- 10-Q · Apr 30, 2026
- 8-K · Apr 29, 2026Results of operations, Financial statements and exhibits
Insider filing activity
CNMD insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
CNMD news
- The top 5 analyst questions from CONMED’s Q3 earnings callOct 31, 2026 · finance.yahoo.com
- CONMED (CNMD) Shares Dropped, So What Is Going On?Oct 31, 2026 · finance.yahoo.com
- CONMED Corporation Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- CONMED Q3 Earnings Call HighlightsOct 29, 2026 · marketbeat.com
- CONMED (CNMD) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- Conmed (CNMD) Q3 Earnings Top EstimatesOct 28, 2026 · finance.yahoo.com
- Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 EarningsOct 28, 2026 · finance.yahoo.com
- CONMED (NYSE:CNMD) posts Q3 2026 sales in line with estimatesOct 28, 2026 · finance.yahoo.com
About CONMED Corporation
CONMED Corporation (CNMD) is a US-listed public company on NYSE. The SEC classifies its business as Electromedical & Electrotherapeutic Apparatus. It is incorporated in DE. Its fiscal year ends in December.